Derma Sciences (DSCI) Launches New MEDIHONEY Hydrogel Sheet Dressings; HCPCS Codes Received
- Top 10 News for 10/17 - 10/21: Merger Rumors Abound; CEOs Depart; Tesla Kicks Autopilot Up A Notch
- Wall Street ends little changed; Microsoft hits record
- AT&T (T) in Advanced Talks to Acquire Time Warner (TWX) - DJ
- Rockwell Automation (ROK) Said to Attract Takeover Interest from Schneider Electric - Source
- British American Tobacco Offers to Acquire Remaining Shares of Reynolds American (RAI) for $56.50/Share
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Derma Sciences, Inc. (Nasdaq: DSCI) announces the launch of new, MEDIHONEY Hydrogel Sheet Dressings and the receipt of Healthcare Common Procedural Coding System (HCPCS) codes awarded on August 19, 2016 by the Centers for Medicare and Medicaid Services (CMS).
Stephen T. Wills, Executive Chairman and Interim Principal Executive Officer of Derma Sciences said, “Derma Sciences is committed to reestablishing access for honey-based wound care products for Medicare patients. MEDIHONEY® Hydrogel is the only medicinal honey-based dressing in the market offering Medicare Part B reimbursement. These dressings, which include four SKUs of MEDIHONEY® Hydrogel, are the first of three products we are reformulating to conform to HCPCS codes. We are looking forward to the launch of two more MEDIHONEY® products into the Medicare market by the end of the year, and believe that we will eventually be able to recapture a significant portion of the sales that were lost following the removal of reimbursable HCPCS codes on February 1, 2015.”
The MEDIHONEY® Hydrogel dressings, for treatment of dry to lightly exuding wounds, have been designed and manufactured to provide a reimbursable honey-based wound care dressing with clinical benefits. The existing MEDIHONEY® HCS dressings will continue to provide value and be available to patients and clinicians in the acute care and private markets.
“We are excited to be able to again offer MEDIHONEY® dressings with reliable Medicare reimbursement following the removal of reimbursable HCPCS codes last year,” said Russell Olsen, President of Derma Sciences’ Advanced Wound Care business. “We worked closely with clinicians as we redesigned the product to meet the requirements of the Local Coverage Determination for Surgical Dressings proposed in August 2015 by the Durable Medical Equipment Medicare Administrative Contractors and we are pleased that these new dressings perform well clinically. All of the honey used in our MEDIHONEY® dressing is made using 100% honey and we follow strict manufacturing controls to ensure its quality and consistency.”
HCPCS codes are used by Medicare and are monitored by CMS. They are based on the Current Procedural Technology (CPT) codes developed by the American Medical Association. Wound dressings and other supplies cannot be reimbursed through Medicare without set HCPCS codes. Additionally, most private health insurance companies follow the lead of Medicare with these types of products.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concordia International (CXRX) CEO to Step Down
- Allstate (ALL), Mastercard (MA) Team on New Payment System
- Retrophin (RTRX) Plans Presentations on Additional Phase 2 DUET Data as FSGS Treatment at ASN Event
Create E-mail Alert Related CategoriesCorporate News, FDA, Management Comments
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!